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ABSTRACT
Patients carrying the carbonic anhydrase12 E143K mutation showed the dry mouth phenotype. The mech-
anism underlying the modulation of aquaporin 5 and function in the salivary glands by carbonic anhy-
drase12 remains unknown. In this study, we identified the mislocalised aquaporin 5 in the salivary glands
carrying the E143K. The intracellular pH of E143K cells was more acidic than that of the cells carrying wild
type. To evaluate the role of carbonic anhydrase12 on the volume regulation of aquaporin 5, the subman-
dibular gland cells were subjected to hypotonic stimuli. E143K enhanced the extent of swelling of cells on
hypotonicity. Aquaporin 5 modulates water influx through ion transporters to prevent osmotic imbalance.
These results suggest that the carbonic anhydrase12 E143K, including acidification or inflammation, medi-
ates volume dysregulation by the loss of aquaporin 5. Thus, carbonic anhydrase12 may determine sensible
effects on the cellular osmotic regulation by modulating aquaporin 5.
ARTICLE HISTORY
Received 9 September 2018
Revised 19 October 2018
Accepted 22 October 2018
KEYWORDS
Carbonic anhydrase 12;
aquaporin 5; volume
regulation; acidosis;
salivary glands
Introduction
Aquaporin 5 (AQP5) is a member of the transmembrane protein
channels involved in transcellular water permeability and a domin-
ant water channel in the epithelia of the salivary and lacrimal
glands and the lung alveoli1,2. A study using AQP5 knockout mice
showed that AQP5 plays a central role in salivary secretion3.
Indeed, AQP5 classically prevents excessive water reabsorption
and modulates cell shape and volume4. Recently, several new
roles of AQP5, in addition to water transport, have been dis-
cussed. AQP5 is involved in migration by activating Ras and Rac
signalling in cancer cells5 and is associated with cancer cell inva-
sion and tumour metastasis through the NF-jB signalling path-
way6. Additionally, hyperosmotic stress-mediated AQP5 expression
mediates the expression of inflammatory cytokines and cell death
through the JNK1/2 MAPK signalling pathway7.
The in vitro trafficking of AQP5 from the intracellular segments to
the plasma membrane was mediated by secretory stimulation caused
by factors such as acetylcholine1. However, in vivo evidence for the
trafficking of AQP5 remains unknown. We focused on patients carry-
ing the carbonic anhydrase 12 (CA12) E143K point mutation who
showed dry mouth phenotype8. In addition, in the ex vivo mouse
model, the volume of saliva secreted from the salivary glands of CA12
E143K (E/K)-mutated mice was dramatically reduced by using the
adenovirus-mediated CA12 E/K gene transfer system8. Downregulated
activities of the electrogenic sodium-bicarbonate co-transporter 1-B
(NBCe1-B) and anion exchanger 2 (AE2) could be partially responsible
for the reduced salivary volume caused by the CA12 E/K mutation.
The higher electrolyte concentration caused by the CA12 E/K muta-
tion indicated reduced water volume8. CA12 is a basolateral mem-
brane-associated enzyme, which possesses the catalytic site at the
extracellular surface, regulating extracellular HCO3
 concentration9.
Typically, the membrane channels of exocrine glands such as salivary
glands are localised with polarisation. AQP5 is expressed at and local-
ised to the luminal membrane of acinar cells10. However, the associ-
ation between CA12 mutation and reduced salivary volume remains
unknown. In our previous study, we showed that the CA12 mutation
mediates abnormal localisation of CA12 in the cytosol8. CAs generate
the acidic component, CO2, as well as the pH buffer ion HCO3
9. The
cytosolic expression of CA12 E/K mutation can be expected to be
modulated by the intracellular pH (pHi). CA12 mutation-induced
modulation of the water channel AQP5 might provide an evidence of
reduced salivary function. In this study, we found the presence of mis-
localised AQP5 in the CA12 E/K-mutated salivary glands in vivo. Thus,
to examine whether CA12 and AQP5 physically associate in the saliv-
ary glands, we designed this study to assess the effects of CA12 and
its E/K mutant on the expression and volume regulation of AQP5.
Here, we address the definitive mechanism employed by CA12 and its
mutant on the volume regulation of AQP5 with respect to the physio-
logical conditions in the exocrine glands.
Material and methods
Reagents and plasmids
b-Actin antibody (A3854), 4,40-diisothiocyano-2,20-stilbenedisulfonic
acid (DIDS; 462268), carbachol (1092009), acetazolamide (A6011),
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and amiloride hydrochloride hydrate (Amiloride; A7410) were pur-
chased from Sigma (Saint-Louis, MO). AQP5 (ab92320), Naþ-Kþ-Cl
co-transporter1 (NKCC1, ab59791), SLC26A6 (ab123001), and AE2
(ab42687) antibodies were purchased from Abcam (Cambridge,
MA). CA12 antibody was purchased from ProteinTech Inc. (15180–1-
AP; Chicago, IL). 2’,7’-Bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein
(BCECF)-AM was purchased from TEFlabs (0061; Austin, TX). TNF-a
(210-TA-005) was purchased from R&D Systems (Minneapolis, MN).
Calcein-AM was purchased from Molecular Probes (C1430; Eugene,
OR). Pluronic acid (F-127, 20% in dimethyl sulphoxide, P-3000MP),
pHrodo Green AM (P35373), and ZO-1 antibody (940–2200) were
purchased from Invitrogen (Carlsbad, CA). All other chemicals were
purchased from Sigma. GFP-tagged human AQP5 was a kind gift
from Kyung Pyo Park (Seoul National University, South Korea), and
DNA plasmids for pcDNA3.0-human NKCC1, mKate-human SLC26A6,
HA-rabbit AE2, mKate-human CA12 wild type, and mKate-CA12
E143K mutants were generously provided by Dr. Shmuel Muallem
(National Institutes of Health, Bethesda)8.
Cell culture
Human embryonic kidney 293 T cells (HEK293T) was maintained in
Dulbecco’s modified Eagle’s medium (Invitrogen, 11995–065) con-
taining 10% fetal bovine serum (FBS; Invitrogen, 16000–044), and
100U/mL penicillin–streptomycin (Invitrogen, 15140–122) and
incubated at 37 C in a humidified environment containing 5%
CO2 and 95% air. When the cells reached 80% confluency, the cul-
ture medium was aspirated, and the cells were washed with
Dulbecco’s phosphate-buffered saline (DPBS, Welgene, South
Korea, LB001-02), followed by their treatment with trypsin/ethyle-
nediaminetetraacetic acid (EDTA) for 2min. The dispersed cells
were transferred to new culture dishes for western blotting and
co-immunoprecipitation (Co-IP) or to culture dishes with glass cov-
erslips for imaging.
Isolation of mouse submandibular glands (SMG) acinar cells
All experimental protocols for animals and their maintenance and
care were undertaken according to the Gachon University Animal
Care guidelines. All animal procedures were approved by the
Center of Animal Care and Use, Lee Gil Ya Cancer and Diabetes
Institute, Gachon University, and the Institutional Animal Care and
Use Committee (IACUC) (Permission number: LCDI-2017–0014).
Mouse SMG cells were isolated from 22–25 g C57BL/6 mice, and
the isolated tissues and cells were suspended in physiological salt
solution A (PSA; 140mM sodium chloride [NaCl], 10mM glucose,
5mM potassium chloride [KCl], 1mM magnesium chloride [MgCl2],
1mM calcium chloride [CaCl2], 10mM HEPES [pH 7.4], 0.02% soy-
bean-trypsin inhibitor, 0.1% sodium pyruvate, and 0.1% bovine
serum albumin [BSA]), and stored on ice until use. The isolated tis-
sues were minced with scissors and incubated in collagenase P
solution (2.5mg/10ml in PSA; Roche) for 6min at 37 C with vigor-
ous shaking. The isolated acinar cells were washed and re-sus-
pended in PSA and stored on ice until use.
Adenovirus-transduced mice
To overexpress the CA in vivo, the adenovirus (Ad)-transduced
mice were developed as previously described8. Briefly, the CA12
and CA12 E143K fragments were generated by PCR and ligated
into pAC-IRES-RFP to generate pAC-CA12-IRES-RFP and pAC-CA12
E/K. Adenoviruses were delivered to 8-week-old C57BL/6 mice.
The mice were anesthetised with the both SMG and parotid
glands cannulated. Saline (50lL for the SMG glands) containing
AdCA12 or AdCA12 E/K (5 109 particles per gland) was then
administered by retrograde ductal instillation. After 7 days, the
SMG were isolated and dissected for immunostaining.
Measurement of CBE and NKCC activities
Isolated SMG cells were attached onto coverslips and loaded in
the chamber containing 6 lM BCECF-AM in the presence of 0.05%
pluronic acid (F-127) in HEPES-buffered solution (Table 1) for
15min at room temperature. After stabilisation of the fluores-
cence, the cells were perfused with solution A for a minimum of
5min prior to measuring the pHi. The pHi was measured by
BCECF fluorescence at dual excitation wavelengths of 495 and
440 nm and an emission wavelength of 530 nm. The chloride/
bicarbonate exchange (CBE) activity of AE2 and SLC26A6 was
determined using Cl-free HCO3
-buffered solution (Table 2) con-
taining 126mM Naþ. The cells were incubated with CO2-saturated
HCO3
-buffered solution (Table 3) for the acidification of the cyto-
sol, and then perfused with Cl-free HCO3
-buffered solution. CBE
activity was calculated from the slope of increase in pHi during
the first 30–45 s in Cl-free HCO3
-buffered solution and
expressed as percent fold change relative to that of the CBE activ-
ity of the control. NKCC1 activity was estimated from the slope of
change in pHi by using 10mM NH4Cl in HEPES-buffered solution.
Administration of NH4Cl in the extracellular solution induced initial
alkalisation by the diffusion of NH3, and then, pHi was decreased
by NH4
þ influx, as a substitution of Kþ. The pHi recovery rate in
the second phase provides NH4
þ influx. The traces were normal-
ised at the time point of NH4Cl administration. The slope of
second-phase acidification was calculated and represented as a
ratio. To mimic intracellular acidification, the isolated SMG cells
were treated with Naþ-free solution (0Naþ, Table 4) and
Amiloride, a sodium channel inhibitor, followed by 10mM NH4Cl
stimulation. Images were obtained at 1-s interval by using a CCD
camera (Retiga 6000; Q-Imaging, Canada) linked to an inverted
microscope (Olympus, Japan), and analysed with a MetaFluor sys-
tem (Molecular Devices, PA). Each image was normalised by sub-
tracting the background fluorescence from the raw
background signals.
Table 2. Composition of Cl-free HCO3
-buffered solution.
Composition Final concentration
Sodium gluconate 120mM
HEPES 2.5mM
Glucose 10mM
Potassium gluconate 5mM
Magnesium sulfate (MgSO4) 1mM
Calcium gluconate 0.5mM
Sodium bicarbonate (NaHCO3) 25mM
pH 7.8
310 mOsm
Table 1. Composition of HEPES-based solution.
Composition Final concentration
Sodium chloride (NaCl) 140mM
HEPES 10mM
Glucose 10mM
Potassium chloride (KCl) 5mM
Magnesium chloride (MgCl2) 1mM
Calcium chloride (CaCl2) 1mM
pH 7.4
300mOsm (310 for SMG)
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Cell acidification
To mimic intracellular acidification, the isolated SMG cells were treated
with 10mM NH4Cl in the extracellular solution induced initial alkalisa-
tion for 1min and subsequently treated with 0Naþ and Amiloride, a
sodium channel inhibitor, for indicated times. Treated SMG cells were
used in the biotinylated assay, pH imaging, and confocal imaging.
DNA transfection
Plasmid DNAs (Total amount of DNA: 2 lg) were incubated in
200 lL of Opti-Eagle’s minimum essential medium (Opti-MEMTM;
Invitrogen, 31985–070) and mixed with the Lipofectamine 2000
mixture. The mixture was incubated at room temperature for
25min and transferred into cell dishes containing culture medium.
After 4 h, the transfected medium was replaced with the fresh cul-
ture medium, and the cells were used at 24 h after transfection.
Plasmid DNA transfection by Lipofectamine 2000 was performed
according to the manufacturer’s protocol (Invitrogen, 11668019).
Measurement of volume changes
The transfected cells and isolated SMG cells were loaded with
2 lM calcein-AM (Molecular Probes) in the presence of 0.01% plur-
onic acid (F-127) for 15min at room temperature. After stabilisa-
tion of fluorescence, the cells were perfused with HEPES-buffered
solution for a minimum of 5min prior to volume measurement.
The calcein-AM dye was excited at 495 nm, and the emitted fluor-
escence was measured at 515 nm. Cell volume was determined
using a hypotonic (215 mOsm, Table 5) or hypertonic (500 mOsm,
Table 6) solution. Fluorescence images were captured at 1-s inter-
val by using a CCD camera (Retiga 6000, Q-Imaging, Canada)
linked to an inverted microscope (Olympus, Japan), and analysed
with a MetaFluor system (Molecular Devices, PA). Each image was
normalised by subtracting the background fluorescence from the
raw background signals.
Co-immunoprecipitation, surface biotinylation and
Western blotting
Transfected cells were incubated with lysis buffer (Cell Signaling,
9803) containing 20mM Tris, 150mM NaCl, 2mM EDTA, 1% Triton
X-100, and a protease inhibitor mixture for 5min at room tem-
perature. The cells were sonicated and centrifuged at 11,000 g
for 15min at 4 C and protein concentration was determined by
Bradford assay (Bio-Rad, Hercules, CA). For Co-IP, the lysate was
treated with 1 lg/mL of the indicated antibodies at 4 C for 16 h
with gentle shaking and added protein G plus agarose beads
(Santa Cruz, SC-2002) for 4 h. The beads were centrifuged at
11,000 g for 2min at 4 C and discard the supernatant and
washed thrice with the lysis buffer at 4 C. The beads were incu-
bated in the sample buffer at 37 C for 15min for protein detach-
ment. Eluted proteins were applied in western blotting. To
demonstrate the surface expression of proteins, the transfected
cells were incubated with 0.5mg/mL EZ-LINK Sulfo-NHS-LC-biotin
(Thermo, 21335) for 30min on ice, and then treated with 100mM
cold glycine solution (in PBS) for 10min. The incubated cells were
washed thrice with PBS buffer and incubated with the lysis buffer.
Cell extracts were centrifuged at 11,000 g for 15min at 4 C. The
supernatants were incubated overnight with Avidin beads
(Thermo, 20347) at 4 C and the beads were washed with the lysis
buffer. Collected beads were heated at 37 C for 15min in the
presence of the sample buffer to recover proteins. The warmed
protein samples were subjected to separation by using sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
and then transferred onto polyvinylidene difluoride (PVDF; Bio-
Rad) membranes soaked in methanol. The membrane was blocked
with 5% nonfat milk solution in TBS-T (Tris-buffered saline [TBS]
and 0.5% Tween-20) for 1 h. The membrane was incubated over-
night with the indicated antibodies at 4 C and washed thrice
with TBS-T. Following washing, the membranes were incubated
with horseradish peroxidase (HRP)-conjugated anti-mouse and
anti-rabbit secondary antibodies, and the protein bands were
visualised using the enhanced luminescent solution (Thermo,
32209). Input and b-actin blots were used as loading control.
Confocal imaging
Transfected cell or sliced SMG tissues were transferred onto cover
glasses and fixed with chilled (20 C) methanol or 4% parafor-
maldehyde. The isolated SMG cells were pre-treated with 20mM
NH4Cl and 100lM DIDS in 0Na
þ solution for intracellular acidifica-
tion 1 h before fixation. Fixed cells were treated with 5% goat
Table 3. Composition of HCO3
-buffered solution.
Composition Final concentration
Sodium chloride (NaCl) 120mM
HEPES 2.5mM
Glucose 10mM
Potassium chloride (KCl) 5mM
Magnesium chloride (MgCl2) 1mM
Calcium chloride (CaCl2) 1mM
Sodium bicarbonate (NaHCO3) 25mM
pH 7.8
300mOsm (310 for SMG)
Table 4. Composition of Naþ-free solution.
Composition Final concentration
NMDG-Cl (pH 7.4) 125mM
HEPES 2.5mM
Glucose 10mM
Potassium chloride (KCl) 5mM
Magnesium chloride (MgCl2) 1mM
Calcium chloride (CaCl2) 1mM
adjusting pH to 7.8 (with. Choline Bicarbonate)
310 mOsm
Table 5. Composition of hypotonic-buffered solution.
Composition Concentration
Sodium chloride (NaCl) 80mM
HEPES 10mM
Glucose 10mM
Potassium chloride (KCl) 5mM
Magnesium chloride (MgCl2) 1mM
Calcium chloride (CaCl2) 1mM
pH 7.4
215 mOsm
Table 6. Composition of hypertonic-buffered solution.
Composition Concentration
Sodium chloride (NaCl) 140mM
HEPES 10mM
Glucose 10mM
Potassium chloride (KCl) 5mM
Magnesium chloride (MgCl2) 1mM
Calcium chloride (CaCl2) 1mM
pH 7.4
500 mOsm
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serum for 1 h at room temperature to block the nonspecific sites.
The cells were incubated overnight with primary antibodies (1:50,
dilution factor) at 4 C, followed by washing thrice with PBS. To
detect bound antibodies, the cells were treated with goat immuno-
globulin G (IgG)-tagged with rhodamine (1:100; Jackson
ImmunoResearch, anti-mouse: 115–025-072, anti-rabbit: 111–025-
144) or fluorescein isothiocyanate (FITC, 1:100; Jackson
ImmunoResearch, anti-mouse: 115–095-071, anti-rabbit: 111–095-
003) for 1 h at room temperature. Following incubation, the cells
were washed thrice with PBS, and the cover glasses were mounted
on glass slides by using Fluoromount-GTM with 40,6-diamidino-2-
phenylindole (DAPI) (Electron Microscopy Sciences, Hatfield, PA,
17984–24). The slides were analysed using a LSM 700 Zeiss confocal
microscope (Carl Zeiss, Germany) with ZEN software (Carl Zeiss).
Statistical analyses
Data from indicated number of experiments were expressed as
the mean± standard error of the mean (SEM). The statistical differ-
ences between the mean values obtained from the two sample
groups were analysed using Student’s t-test parametric. Statistical
significance was determined by the analysis of variance in each
experiment (p< .05).
Results
Basolateral CA12 mutation disrupts the localisation of AQP5 in
salivary glands
CA12 is expressed in the basolateral membrane of the acinar and
duct cells of the parotid glands8. CA12 E143K (E/K) mutation
caused reduced secretion of ductal fluids in sealed ducts and
inhibited salivation in mice8. The total volume of secreted saliva in
adenovirus-transduced CA12 E/K was dramatically reduced. In this
study, we explored the effect of CA12 and CA12 E/K on the regu-
lation of the water channel AQP5, localised in the luminal mem-
brane as a major water channel in the salivary glands11–13
(Supplementary Figure 1). Adenovirus injection was administered
to the two SMG and the two parotid glands to enhance the effi-
cacy of viral transfer; the SMG was isolated after 7 days and isolated
acinar cells were used for immunostaining. We found mis-localised
AQP5 in CA12 E/K-overexpressed salivary glands (Figure 1(A)). To
confirm the mis-localisation of AQP5 mediated by CA12 E/K, mKate-
CA12WT and -mutant were over-expressed in HEK293 cells with
GFP-tagged AQP5. The CA12 E/K mutation mediated localisation of
AQP5 in the cytosol, not in the plasma membrane (Supplementary
Figure 2). Surface biotinylated assay also revealed about 60%
reduced expression of AQP5 in the presence of CA12 E/K (Figure
1(B,C)). Native AQP5 and CA12 were localised in the luminal and
basolateral membrane of the SMG, respectively (Figure 1(D)).
Although no physical interaction was observed between CA12 and
AQP5 by immunoprecipitation assay, it is not known how basolat-
eral CA12 regulates the expression of luminal AQP5.
Intracellular pH modulates AQP5 expression in SMG
Our previous study showed that CA12WT is membrane-associated,
whereas CA12 E/K mutant can be observed in the cytosol8. CAs
generate an acidic component, CO2
9, and cytosolic CA12 E/K can
be modulated by the intracellular pH (pHi). We speculated that
fluctuations in the basal pHi level might cause AQP5 localisation.
Measurement of the pHi by BCECF showed that the basal pH of
CA12 E/K was about 20% lower than that of CA12WT in HEK293T
cells (Figure 2(A)). HEK293T cells were also stained with pH
indicator pHrodo-green. Overexpressed CA12 E/K revealed the
enhanced intensity, which represented that CA12 E/K-transfected
cells were more acidic (Figure 2(B)). We evaluated the effect of
pHi on the localisation of AQP5. When the isolated SMG cells were
treated with NH4Cl, the initial pHi was alkalised by the diffusion of
NH3 and subsequently acidified by NH4
þ influx. In the presence of
amiloride, an inhibitor of amiloride-sensitive NHE and NBC14, the
pHi moved to the acidic end, and the recovery response was
delayed, indicating the inhibition of Hþ extrusion and HCO3

uptake in order to maintain the acidic pHi (Figure 2(C)). We also
evaluated the surface expression of AQP5 by using the biotiny-
lated assay at acidified pHi. The isolated SMG cells were stimu-
lated in DIDS, followed by NH4Cl stimulation. The surface
expression of AQP5 was diminished by acidosis (Figure 2(D)).
Additionally, the isolated SMG cells were administered NH4Cl, and
subsequently exposed to DIDS in Naþ-free solution to acidify the
pHi, and AQP5 expression was studied using confocal microscopy.
Luminal AQP5 expression of SMG acinar cells was almost absent
under acidic conditions (Figure 2(E)). These results showed that
pHi modulates the membrane expression of AQP5 in SMG.
Stimulation of the salivary gland cells results in bulk water efflux
and can be observed as cell shrinkage15, whereas water influx results
in cell swelling. AQP5 has been known as an osmosensor16. To evalu-
ate the volume regulation of AQP5 in salivary glands, isolated SMG
acinar cells were stimulated in a hypotonic (215 mOsm) solution, and
the volume change was measured using the calcein-AM fluorescent
technique. Shrinkage of SMG cells and increase in fluorescence inten-
sity were observed when moved to a hypertonic solution, while swel-
ling of SMG cells and decrease in fluorescence intensity were elicited
when moved to a hypotonic solution (Supplementary Figure 3A). The
mRNA and protein levels of AQP5 at different levels of tonicity did
not alter the expression level (Supplementary Figure 3(B,C)). We eval-
uated the volume regulation of AQP5 under acidified conditions. The
isolated SMG cells showed an increase in cell swelling under hypo-
tonic stimulation (Figure 2(F,G)). These results suggest that intracellu-
lar acidification reduced the expression of AQP5 and subsequent
volume dysregulation. Mutation of CA12 also provided the acidic
environment in cytosolic area (Figure 2(H)).
CA12 E/K mutation modulates the volume regulation of AQP5
In response to inflammation, the transport of salt and water is
decreased to provide physiological protection17,18. The stimulation
of TNF-a, a primary component of inflammation, reduces saliva
secretion. Isolated SMG cells were pre-treated with TNF-a to con-
firm the volume regulation occurring during inflammation. We
found that TNF-a mediated the increase in cell swelling through
the attenuation of AQP5 (Figure 3(A,B)). We administered the CA
inhibitor acetazolamide, a well-known diuretic19,20. Acetazolamide
inhibited the swelling property of cells (Figure 3(A,B)). To confirm
the effect of acidification and acetazolamide stimulation on the
swelling property of cells, isolated SMG cells were stimulated
using the cholinergic agonist carbamyl chlorine chloride (carba-
chol) to activate fluid secretion (Figure 3(C)). Stimulation of fluid
secretion by carbachol results in large water efflux and cell shrink-
age in the salivary glands15. Isolated SMG cells were found to
shrink by carbachol stimulation. However, in the presence of intra-
cellular acidification and TNF-a stimulation, isolated SMG cells did
not shrink and the volume was maintained (Figure 3(D)), suggest-
ing that the loss of AQP5 caused volume dysregulation in the
presence of the agonist of fluid secretion.
To determine whether CA12 E/K mutation mediates volume
dysregulation, we performed volume measurement in CA12 and
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AQP5-overexpressed HEK293T cells. The volume of CA12WT-
enriched cells was not modulated by the hypotonic stimulation
(Figure 3(E)). The hypotonic solution elicited an increase in the
cell swelling property in the presence of CA12 E/K mutation, sug-
gesting dysfunction of the cytosolic AQP5 induced by CA12 E/K
mutation in response to hypotonicity (Figure 3(F)). These results
suggest that the endogenous acidosis caused by inflammatory sig-
nals, including CA12 E/K mutation, mediate concomitant
internalised expression of AQP5 and obviously dysregulate the
volume in salivary glands.
AQP5 is functionally associated with the transepithelial
transporter AE2
To the best of our knowledge, AQP-mediated fluid movement is
regulated by an osmotic gradient21. To provide a basis for
Figure 1. Basolateral CA12 mutation disrupts the localisation of AQP5. (A) Localisation of AQP5 (green) in the submandibular gland (SMG) after delivering the adeno-
viral CA12 or CA12 E/K. (B) Effect of mKate-CA12 and mKate-CA12 (E/K) on the surface expression of AQP5 in transfected HEK293T cells. (C) The columns represent the
mean± standard error of mean (SEM) of AQP5 surface expression (p< .05, indicated by an asterisk, n¼ 4). (D) Native expression of AQP5 (red) and CA12 (green) in
mouse SMG.
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understanding the role of AQP5 in transepithelial ion transport, we
examined whether these solute transporters modulate volume regu-
lation of AQP5 in the salivary glands. Various transporters are
expressed and involved in salivary function. Among them, AE2 was
found to be modulated by CA12, in our previous study8. The AE2
localised in the plasma membrane and several dots of AE2 co-local-
ised with the tight junction marker ZO-1 (Figure 4(A,B)). The direct
interaction of membrane proteins indicate that these proteins are
functionally linked16. We confirmed the protein–protein interaction
of AE2 and AQP5 in SMG cells and an overexpressed system in
HEK293T cells (Figure 4(C), Supplementary Figure 4A). The volume
regulation of AQP5 was independent of AE2, whereas AE2-overex-
pressed cells showed enhanced swelling property (Figure 4(D)). We
next evaluated the changes of pHi by using the BCECF-AM to meas-
ure the HCO3
-transporting activity. Interestingly, AE2 activity was
enhanced in the presence of AQP5 (Figure 4(E)).
AQP5 is functionally associated with the transepithelial
transporter NKCC1
To assess the relationship between transepithelial ion transport
and volume regulation, we confirmed that another solute-trans-
porting system NKCC1 is physiologically associated with AQP5.
NKCC1 and AQP5 co-localised in the lumen of acinar cells and
interacted with each other (Figure 5(A–C)). We confirmed the pro-
tein–protein interaction of NKCC1 and AQP5 in an overexpressed
Figure 2. Intracellular pH modulates AQP5 expression in SMG. (A) Analysis of the intracellular resting pH level (ratio) of HEK293T cells transfected with CA12 or CA12
E/K (p<.05, indicated by an asterisk, n¼ 7). (B) pHrodo staining (green) images of HEK293T cells transfected with CA12 or CA12 E/K. Enhanced intensity represented
acidic pH. (C) pH changes during the NH4
þ-pulse acidification technique. Upon removal of 10mM NH4Cl solution after the influx of NH4
þ, the cells were acidified using
the remaining Hþ. Amiloride (500lM) was used to inhibit Naþ reabsorption through the Naþ channel. (D) Surface expression of AQP5 during intracellular acidification
with 10mM NH4Cl and 100lM DIDS in 0 Na
þ solution (Naþ-free solution). (E) Changes in AQP5 localisation during intracellular acidification with 10mM NH4Cl and
100lM DIDS in 0 Naþ solution for the indicated time period. SMG acinar cells were stained with DAPI (blue) to indicate the presence of AQP5 (red). (F) Cells were
stimulated in a hypotonic (215 mOsm) solution, and the change in volume was measured using 2lM calcein-AM. The changes in the volume of acidification-induced
SMG acinar cells (using 10mM NH4Cl and 100lM DIDS in 0 Na
þ solution for 30min) were measured. The isolated mouse SMG acinar cells were stimulated in
the hypotonic (215 mOsm) solution. (G) The columns show the mean± SEM of the normalised rate of volume change (F/F0S1, p<.05, indicated by an asterisk, n¼ 5).
(H) Schematic illustration of function and trafficking of CA12 wild type and E/K mutant.
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system of HEK293T cells (Supplementary Figure 4B). Volume regu-
lation of AQP5 was maintained with and without NKCC1 (Figure
5(D)). AQP5 also enhanced NKCC activity, like AE2 activity (Figure
5(E)). It is noted that the solute transporters-overexpressed system,
including AE2 and NKCC1, which only exists in native water chan-
nels, enhanced the swelling property (Figures 4(D) and 5(D)).
Collectively, these results suggest that the activities of AE2 and
NKCC were supported by AQP5 for osmotic regulation, suggesting
that the membrane expression of AQP5 affects the swelling prop-
erty in the presence of solute influx. Normal expression of CA12
also provides HCO3
 consumption and water source to transporters
and AQP5, respectively (Figure 5(F)). The Cl-HCO3
 exchanger AE2
and solute carrier transporter family 26 (SLC26) A6 are abundantly
expressed in the plasma and luminal membranes of salivary glands,
respectively, as acid loaders22. Another luminal protein SLC26A6
was independent of AQP5, with no changes in activity or protein–-
protein interaction (Supplementary Figure 5).
Discussion
Dysregulated volume homoeostasis in the salivary glands plays an
important role in the secretion of fluid and saliva. AQP5 is
Figure 3. CA12 E/K mutation modulates volume regulation of AQP5. (A) Volume regulation of AQP5 on stimulation with a hypotonic (215 mOsm) solution pre-treated with
100lM acetazolamide and 10ng/mL TNF-a for 1 h. (B) The columns represent the mean±SEM of the normalised rate of volume change (F/F0S1, p<.05, indicated by an
asterisk, n¼ 4). (C) Volume regulation of SMG on stimulation of 10lM carbachol with and without treatment with 100lM acetazolamide and 10ng/mL TNF-a for 1 h,
followed by acidification. (D) The columns represent the mean±SEM of the fold changes of cell shrinkage after carbachol treatment (p<.05, indicated by an asterisk, n¼ 3).
(E and F) Volume regulation of AQP5 by stimulation in a hypotonic (215 mOsm) solution with and without CA12 and CA12 E/K. The columns represent the mean±SEM of
normalised rate of volume change (F/F0S1, p<.05, indicated by asterisk, n¼ 6). (G) Schematic illustration of cross talk mechanism to affect AQP5 localisation.
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involved in transcellular water permeability and is a dominant
water channel in the epithelia of the salivary and lacrimal glands,
and the lung alveoli1,2. Appropriate expression of AQP5 in the
luminal membrane aids homoeostatic volume regulation. In this
study, we found that the regulatory factors, endogenous acidifica-
tion, inflammatory factors, and CA12 E/K mutation, all mediate the
dysregulation of AQP5. Basically, decreased AQP5 expression
might reduce water intake. However, enhanced cell swelling by
decreased AQP5 expression in the plasma membrane might indi-
cate ion transporter-mediated volume dysregulation in the
absence of AQP5. Movement of solutes by ion transporters is
accompanied by the movement of water through AQP5. Intrinsic
modulation by acidosis might affect the expression of AQP5 in the
plasma membrane.
The present findings show that the effect of the CA12 E/K
mutation, expressed in the cytosol, mediated the mistargeting of
AQP5. The membrane-associated CAs promote extracellular acidifi-
cation23. The mislocalised CA12 E/K in the cytosol can mediate
aberrant pHi homoeostasis. Our results provide strong evidence
that AQP5 expression is sensitive to pHi. Abnormal localisation of
CA12 E/K mutation generates an acidic intracellular environment,
and pHi-sensitive components such as AQP5 can be affected. We
speculated that reduced expression of AQP5 by CA12 E/K pro-
vided an ion transporter-rich state in the plasma membrane. The
movement of solutes by ion transporters such as AE2 and NKCC1
can be acutely diluted by water to prevent osmotic imbalance.
The cross-talk between ion transporters and AQP5 might maintain
complementary volume regulation. The osmotic maintenance of
AQP5 with transepithelial ion transporters is a typical process in
volume regulation. Disruption of AQP5 expression by CA12 E/K
can provide another candidate mechanism for reduced saliv-
ary volume.
Human CA12 mutation, which results in autosomal recessive
hereditary hyperchlorhidrosis, reduces CA activity and leads to
an autosomal-recessive phenotype, including excessive Cl
secretion in sweat24. CAs are involved in the reverse reaction
involving CO2 and water to release H
þ and HCO3
9.
Mammalian CAs are identified in the cytoplasmic (CA2 and
CA7), mitochondrion-associated (CA5), secretory (CA6), and
plasma membrane-associated (CA4, CA9, CA12, and CA14)
Figure 4. AQP5 is functionally associated with the transepithelial transporter AE2 (A) Native localisation of DAPI (blue), AE2 (red), and ZO-1 (green) in the mouse SMG.
(B) High-magnification images of the co-staining areas in (a) and (b). (C) Co-immunoprecipitation (Co-IP) of AE2 and AQP5 in isolated SMG. (D) Volume regulation of
AQP5 with and without AE2 by hypotonic stimulation in HEK293T cells. The columns represent the mean± SEM of the normalised rate of volume change (F/F0S1,
n¼ 5). (E) Effect of AQP5 on the chloride/bicarbonate exchanger (CBE) activity of AE2-transfected HEK293T cells. The columns represent the mean± SEM of CBE activity
(p< .05, indicated by an asterisk, n¼ 3).
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enzymes9. The plasma membrane-localised CAs functionally cou-
ple with and regulate the activity of HCO3
 transporters, includ-
ing NBCe1 and AE28,25,26. Although the functional role of CAs
in fluid and HCO3
 secretion, including AQP5, is obvious, the
functional and physiological interactions between other type of
CAs and AQP5 are still unclear.
In this study, we, for the first time, to the best of our know-
ledge, provided direct evidence of the modulatory role of CA12
on AQP5 expression. Dysregulation of AQP5 by the CA12 defi-
ciency caused by CA12 E/K mutation might involve excessive Cl
secretion, resulting in hyperchlorhidrosis in humans. In addition,
for the cancer treatment, several blockades of oncogene CA12
have been developed27–29. Accordingly, intracellular acidification,
inflammation, or application of blockades of oncogene CA12
should be induced osmotic dysregulation in case of volume-sensi-
tive exocrine glands such as the salivary glands, which abundantly
express AQP5.
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